Evidence map›Paper›PMID 26022821›Full record

ArticleJournal of the American College of Cardiology2015

Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.

Robert A McDonald, Crawford A Halliday, Ashley M Miller, Louise A Diver, Rachel S Dakin, Jennifer Montgomery, Martin W McBride, Simon Kennedy, John D McClure, Keith E Robertson and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Pro-Healing Nanomatrix-Coated Stent Analysis in anACS applied materials & interfaces · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hypersensitivity and in-stent restenosis in coronary stent materials.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Robert A McDonaldInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Crawford A HallidayInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Ashley M MillerInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Louise A DiverInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Rachel S DakinInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Jennifer MontgomeryInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Martin W McBrideInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Simon KennedyInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
John D McClureInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Keith E RobertsonInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
Gillian DouglasWest of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital, Clydebank, Scotland.
Keith M ChannonWest of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital, Clydebank, Scotland.
Keith G OldroydDepartment of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Andrew H BakerInstitute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland. Electronic address: andrew.h.baker@glasgow.ac.uk.
University of Glasgow · GBGolden Jubilee National Hospital · GBJohn Radcliffe Hospital · GB

Funding

British Heart Foundation CH/11/2/28733British Heart Foundation FS/11/12/28673British Heart Foundation FS11/12/28673British Heart Foundation RG/09/005/27915British Heart Foundation RG/12/5/29576British Heart Foundation RG/14/3/30706Wellcome Trust 090532
6 · The paper itself

Abstract

backgroundDrug-eluting stents reduce the incidence of in-stent restenosis, but they result in delayed arterial healing and are associated with a chronic inflammatory response and hypersensitivity reactions. Identifying novel interventions to enhance wound healing and reduce the inflammatory response may improve long-term clinical outcomes. Micro-ribonucleic acids (miRNAs) are noncoding small ribonucleic acids that play a prominent role in the initiation and resolution of inflammation after vascular injury.

objectivesThis study sought to identify miRNA regulation and function after implantation of bare-metal and drug-eluting stents.

methodsPig, mouse, and in vitro models were used to investigate the role of miRNA in in-stent restenosis.

resultsWe documented a subset of inflammatory miRNAs activated after stenting in pigs, including the miR-21 stem loop miRNAs. Genetic ablation of the miR-21 stem loop attenuated neointimal formation in mice post-stenting. This occurred via enhanced levels of anti-inflammatory M2 macrophages coupled with an impaired sensitivity of smooth muscle cells to respond to vascular activation.

conclusionsMiR-21 plays a prominent role in promoting vascular inflammation and remodeling after stent injury. MiRNA-mediated modulation of the inflammatory response post-stenting may have therapeutic potential to accelerate wound healing and enhance the clinical efficacy of stenting.

Indexed as

Drug-Eluting StentsVascular RemodelingAnimalsCoronary RestenosisInflammationMaleMice, KnockoutMicroRNAsSwineVascular System InjuriesMicroRNAsMIRN21 microRNA, mouselate stent thrombosismiRNA stem loopneointimasmooth muscle cell

Identifiers

PMID26022821
PMCPMC4444526
OpenAlexW1847840776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.